VelaVigo Announces Second Out-Licensing Deal, of a First-in-Class Bi-specific Antibody, Further Validating Its Innovative Discovery Platform and Sustainable BD+VC Business Model ...Middle East

SHANGHAI and BOSTON, April 17, 2025 /PRNewswire/ -- VelaVigo Bio, the U.S. subsidiary of VelaVigo Cayman Limited (VelaVigo), a biotech company with a robust discovery and development platform of multi-specific antibodies and antibody-drug conjugate (ADC), today announced its second...

Read More Details
Finally We wish PressBee provided you with enough information of ( VelaVigo Announces Second Out-Licensing Deal, of a First-in-Class Bi-specific Antibody, Further Validating Its Innovative Discovery Platform and Sustainable BD+VC Business Model )

Also on site :

• Country Star Reveals He Soiled Himself Onstage in Major 'TMI' Moment
• ‘He’s got MS-13 tattooed onto his knuckles’: Trump appears to hold up photoshopped image of Abrego Garcia’s hand
• 'Fire Country' Star Stephanie Arcila Goes Inside Gabriela’s Stalker Storyline (Exclusive)